DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Infollion Research Services Limited — Board Meeting Intimation

NSE 1 hr ago·12 Oct 2026, 5:08 am

Infollion Research Services

Infollion Research Services Limited has announced that its board will meet on October 15, 2026, to review and approve the company's unaudited financial results for the first half of the fiscal year ending September 2026.

This update is significant for investors as it provides an early glimpse into the company's operational performance and financial health during the first six months of the year. The results will help the market assess the company's current trajectory and growth potential.

Investors should watch for the specific financial metrics disclosed in the results, including revenue growth, profit margins, and any commentary from management regarding future outlook. The release of these figures will likely influence the stock's short-term trading sentiment.